Detalhes bibliográficos
| Ano de defesa: |
2009 |
| Autor(a) principal: |
Sousa, Jorge Andre Rocha de
 |
| Orientador(a): |
Amorim, Maria Cristina Sanches |
| Banca de defesa: |
Não Informado pela instituição |
| Tipo de documento: |
Dissertação
|
| Tipo de acesso: |
Acesso aberto |
| Idioma: |
por |
| Instituição de defesa: |
Pontifícia Universidade Católica de São Paulo
|
| Programa de Pós-Graduação: |
Programa de Estudos Pós-Graduados em Administração
|
| Departamento: |
Faculdade de Economia, Administração, Contábeis e Atuariais
|
| País: |
BR
|
| Palavras-chave em Português: |
|
| Palavras-chave em Inglês: |
|
| Área do conhecimento CNPq: |
|
| Link de acesso: |
https://tede2.pucsp.br/handle/handle/1363
|
Resumo: |
The main objective of this present job is to discuss the Pharmacy benefit management and its analyses resulting from medicines consuming information, in special on the consuming of antihypertensive drugs. The research theme is based on the preventive actions necessity targeted to users with chronic conditions. The patients with hypertension or high blood pressure was chosen for analyses based on the fact that the diseases of the cardiovascular system presents the biggest rate of mortality with 32% of the incidents, (chapter 1) also being, at the range over the age of 50 years old, and its responsible for 27,5% of the admissions recorded (CIS-MS-2007). The changes in the health sector, through the regulate agency, ANS, accordingly approached on the 2nd chapter indicates a tendency towards preventive actions. The companies that compound the health supplementary sector passed by process standard of the products and the procedures roll, generating one new dynamic in the sector, doing that the level of the risk index assumed both strong performance and financial indicator. In this scenario arise the PBMS (the Pharmacy Benefit Management), with the proposal to play the role of administer the drugs for what the components of the health management, information management. This approach, discussed in the chapter 3 and 4, tried to understand the movement in the sector provoked by the proposals of the health management on the pharmaceutical retail behaving. The study was conducted analyzing the antihypertensive drugs among 42.145 users of three companies localized of São Paulo and Paraná, with the policies of subsidy on drugs that varied of 35% to 90% of the price of sales. The methodology utilized was the data base direct investigation of the all registers of sales of the year 2008, comparing the results of the numbers identified consuming the products for hypertensive with estimative on the index of the prevalence of the high blood pressure and the incidence of the adverse events. It seems that is clear the users with major level of subsidy tends to follow more correctly the therapeutic prescriptions and, potentially reduces the index of risks to aggravate of the health state. The return of subsidy investment reached the range of the 20,2% through 80,6%, respectively the subsidy ranges between 35% and 90% |
